Vytrus Biotech (Spain) Performance
| VYT Stock | 2.88 0.04 1.41% |
On a scale of 0 to 100, Vytrus Biotech holds a performance score of 22. The entity has a beta of -0.32, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Vytrus Biotech are expected to decrease at a much lower rate. During the bear market, Vytrus Biotech is likely to outperform the market. Please check Vytrus Biotech's value at risk, kurtosis, market facilitation index, as well as the relationship between the semi variance and rate of daily change , to make a quick decision on whether Vytrus Biotech's existing price patterns will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Vytrus Biotech SA are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Vytrus Biotech exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Vytrus |
Vytrus Biotech Relative Risk vs. Return Landscape
If you would invest 220.00 in Vytrus Biotech SA on December 22, 2024 and sell it today you would earn a total of 68.00 from holding Vytrus Biotech SA or generate 30.91% return on investment over 90 days. Vytrus Biotech SA is generating 0.4478% of daily returns assuming 1.6002% volatility of returns over the 90 days investment horizon. Simply put, 14% of all stocks have less volatile historical return distribution than Vytrus Biotech, and 91% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Vytrus Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vytrus Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Vytrus Biotech SA, and traders can use it to determine the average amount a Vytrus Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2798
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VYT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.6 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.45 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.28 actual daily | 22 78% of assets perform better |
Based on monthly moving average Vytrus Biotech is performing at about 22% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vytrus Biotech by adding it to a well-diversified portfolio.
Things to note about Vytrus Biotech SA performance evaluation
Checking the ongoing alerts about Vytrus Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vytrus Biotech SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Vytrus Biotech's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Vytrus Biotech's stock performance include:- Analyzing Vytrus Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vytrus Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Vytrus Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vytrus Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vytrus Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vytrus Biotech's stock. These opinions can provide insight into Vytrus Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Vytrus Stock analysis
When running Vytrus Biotech's price analysis, check to measure Vytrus Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vytrus Biotech is operating at the current time. Most of Vytrus Biotech's value examination focuses on studying past and present price action to predict the probability of Vytrus Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vytrus Biotech's price. Additionally, you may evaluate how the addition of Vytrus Biotech to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |